NASDAQ NMS - GLOBAL MARKET · BTMD
-8.67% · -$0.1700 · Vol 3.3M
Market closed · last close 4:00 PM ET · price as of 16:31:50 ET
Biote Corp

Biote Corp

Pharmaceuticals
$1.79
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is BTMD moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Biote Corp
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Listed since
2022
Employees
223
Country
US

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.97
Day high
$2.09
Day low
$1.77
Previous close
$1.96
52W high
$2.39
-25.10% from high
52W low
$1.77
3% of range
Market cap
$59.4M
P/E
2.39×
EPS
$0.7500
Shares out
30.3M
Volume
3.3M
VWAP
$1.81
Price history computed in-house
1W
-20.80%
SMA 50 $2.20 · below
SMA 200 $2.20 · below
52W position 3%
Veridion warehouse edge

Warehouse intelligence for BTMD.

Veridion Score
79
0: 951: 442: 703: 504: 775: Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

BTMD insider activity

Biote Corp

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for BTMD.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

BTMD contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BTMD in this window.
Lobbying spend

BTMD lobbying filings, year to date.

Registered lobbying filings matched to Biote Corp.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BTMD in this window.
Latest news · BTMD
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for BTMD.
Options
Sovereign unlock shows live options positioning for BTMD.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.